Kinesin motor proteins play a fundamental role for normal neuronal development by controlling intracellular cargo transport and microtubule (MT) cytoskeleton organization. Regulating kinesin activity is important to ensure their proper functioning, and their misregulation often leads to severe human neurological disorders. Homozygous nonsense mutations in kinesin-binding protein (KBP)/KIAA1279 cause the neurological disorder Goldberg-Shprintzen syndrome (GOSHS), which is characterized by intellectual disability, microcephaly, and axonal neuropathy. Here, we show that KBP regulates kinesin activity by interacting with the motor domains of a specific subset of kinesins to prevent their association with the MT cytoskeleton. The KBP-interacting kinesins include cargo-transporting motors such as kinesin-3/KIF1A and MT-depolymerizing motor kinesin-8/KIF18A. We found that KBP blocks KIF1A/ UNC-104-mediated synaptic vesicle transport in cultured hippocampal neurons and in C. elegans PVD sensory neurons. In contrast, depletion of KBP results in the accumulation of KIF1A motors and synaptic vesicles in the axonal growth cone. We also show that KBP regulates neuronal MT dynamics by controlling KIF18A activity. Our data suggest that KBP functions as a kinesin inhibitor that modulates MT-based cargo motility and depolymerizing activity of a subset of kinesin motors. We propose that misregulation of KBPcontrolled kinesin motors may represent the underlying molecular mechanism that contributes to the neuropathological defects observed in GOSHS patients.
SUMMARY
Kinesin motor proteins play a fundamental role for normal neuronal development by controlling intracellular cargo transport and microtubule (MT) cytoskeleton organization. Regulating kinesin activity is important to ensure their proper functioning, and their misregulation often leads to severe human neurological disorders. Homozygous nonsense mutations in kinesin-binding protein (KBP)/KIAA1279 cause the neurological disorder Goldberg-Shprintzen syndrome (GOSHS), which is characterized by intellectual disability, microcephaly, and axonal neuropathy. Here, we show that KBP regulates kinesin activity by interacting with the motor domains of a specific subset of kinesins to prevent their association with the MT cytoskeleton. The KBP-interacting kinesins include cargo-transporting motors such as kinesin-3/KIF1A and MT-depolymerizing motor kinesin-8/KIF18A. We found that KBP blocks KIF1A/ UNC-104-mediated synaptic vesicle transport in cultured hippocampal neurons and in C. elegans PVD sensory neurons. In contrast, depletion of KBP results in the accumulation of KIF1A motors and synaptic vesicles in the axonal growth cone. We also show that KBP regulates neuronal MT dynamics by controlling KIF18A activity. Our data suggest that KBP functions as a kinesin inhibitor that modulates MT-based cargo motility and depolymerizing activity of a subset of kinesin motors. We propose that misregulation of KBPcontrolled kinesin motors may represent the underlying molecular mechanism that contributes to the neuropathological defects observed in GOSHS patients.
INTRODUCTION
Kinesin motors are a large family of related motor proteins that are essential for various microtubule (MT)-based processes during neuronal development. Kinesins drive vesicle transport, organize the localization of organelles, and control MT dynamics in both axons and dendrites [1] [2] [3] . Several mechanisms exists that control kinesin motor activity, both at the level of motor-cargo and motor-MT interactions [4, 5] . One important mechanism by which motor proteins are regulated includes the suppression of motor activity by autoinhibition, which has been best studied for kinesin-1 family members [6] . In the absence of cargo, inactive kinesin-1 exists in a folded conformation, allowing the tail domain to bind and inhibit its motor domain [7] . Cargo binding of the tail region subsequently relieves autoinhibition and enables MT-based motility [8, 9] . However, whether other kinesin inhibitory mechanisms exist is unknown.
Human genetics studies showed that homozygous nonsense mutations in the gene encoding kinesin-binding protein (KBP/ KIAA1279) were linked to Goldberg-Shprintzen syndrome (GOSHS), a severe neurological disorder characterized by intellectual disability, polymicrogyria, microcephaly, and axonal neuropathy [10] [11] [12] . KBP was originally identified as a KIF1C-binding protein [13] and was found to be associated with other members of the kinesin family [14, 15] . Furthermore, KBP has been suggested to associate with the cytoskeleton [16, 17] and shown to be required for axonal outgrowth in zebrafish [18] . Interestingly, electron microscopy analysis of the KBP zebrafish mutants revealed MT defects and aberrant organelle accumulations in the axon [18] . However, the function of KBP and its putative role in regulating MT dynamics and cargo transport has remained unresolved.
In this study, we found that KBP binds to the motor domain of a specific set of kinesin family members and regulates kinesin activity by preventing the association of the kinesin with MTs. Our findings suggest that KBP functions as a specific kinesin inhibitor that modulates MT-based motility and depolymerizing activity of distinct kinesin motors. Inhibition of kinesin activity by KBP provides a novel control mechanism for kinesin motor protein function. (legend continued on next page)
RESULTS

KBP Binds to the Motor Domain of a Specific Subset of Kinesin Motor Proteins
KBP was originally identified in a yeast two-hybrid screen as a KIF1C-binding protein [13] and was found to be associated with other members of the kinesin-3 family [14, 15] . To identify additional KBP-binding partners, we made use of pull-down assays combined with mass spectrometry using biotinylated and GFP-tagged KBP (bio-GFP-KBP) in HEK293 or HeLa cells. Several types of kinesin motors were identified in this analysis: the kinesin-2 motor KIF3A; members of the kinesin-3 family, including KIF1A, KIF1B, KIF1C, KIF13B, and KIF14; kinesin-8 motor KIF18A; and kinesin-12 motor KIF15 ( Figure 1A ). Other molecular motors, such as components of the dynein/dynactin motor complex or myosin proteins, kinesin-1 (KIF5/KHC), kinesin-4 (KIF21), kinesin-13 (KIF2/M-kinesins), and kinesin-14 (KIFC/C-kinesins), were not detected in the KBP pull-down experiments. To validate the mass spectrometry results and to further narrow down the kinesin-KBP interaction, we conducted pull-down and immunoprecipitation experiments using KBPspecific antibodies (Figures S1A and S1B). Using a panel of GFP-tagged kinesin proteins containing only the motor domain and the first coiled-coil region (MDC), we could confirm that endogenous KBP binds to the same subset of kinesins that were identified by mass spectrometry ( Figures 1D and 1E) . Consistent with the mass spectrometry results, several other kinesin family members, including the kinesin-1 motor KIF5B and the kinesin-4 motor KIF21B, or components of the dynein motor did not pull-down endogenous KBP ( Figures 1C, 1D , and S1D), indicating that KBP binds to a specific subset of kinesin motor proteins. Using similar pull-down and immunoprecipitation assays, we could not detect the previously described association between the stathmin-like protein SCG10 and KBP [16] ( Figures  1C and S1D ). To corroborate that KBP binds specifically to the motor domain as suggested by our pull-down experiments ( Figures  1D and 1E ), we performed additional immunoprecipitation experiments with constructs containing either the MDC domain or the whole stalk/tail region (tail) of the kinesin-3 family members KIF1A and KIF1C ( Figure 1F ). In agreement with the previous experiments ( Figures 1A and 1D ), KBP did not interact with any of the kinesin tail constructs but associated with the motor domains of KIF1A and KIF1C, whereas it showed no interaction with full-length KIF5B or its motor domain ( Figures 1C, 1F , and S1D). Furthermore, KBP is also able to interact with a single motor domain of KIF1A, without the coiled-coil region (MD; Figure 1G) . By expressing truncated versions of KBP, we tried to map the minimal kinesin-binding region of KBP ( Figure S1A ). Whereas none of the N-terminal (amino acids [aa] 1-292) and C-terminal (aa 292-621) fragments of KBP were able to interact with any of the kinesin constructs, full-length KBP (aa 1-621) bound to endogenous KIF1C, KIF14, and KIF15 ( Figures 1B  and S1C ).
In Vitro Characterization of KBP and Its Interaction with the Motor Domain of KIF1A To further characterize the function of KBP in vitro, we used affinity-purified, recombinant KBP from bacteria ( Figure 1J , lane 1). We first conducted multiangle light scattering (MALS) experiments to assess the oligomerization state of KBP in solution and obtained a molecular mass of 69.7 kDa ( Figure 1K , red line), which is consistent with the molecular mass of monomeric KBP (71.9 kDa). Circular dichroism (CD) spectroscopy measurements of KBP revealed a far-UV spectrum characteristic of proteins with substantial a-helical content ( Figure 1L ). The stability of KBP was assessed by a thermal unfolding profile recorded by CD at 222 nm ( Figure 1M ), which revealed a single sharp transition with a melting temperature, Tm, centered at 53 C. These findings are consistent with sequence analysis and structure predictions, which indicate that KBP exhibits an alpha-alpha superhelix type of fold formed by three tetratricopeptide-like repeats (TPR) ( Figure S1A ).
To study the interaction between KBP and kinesin in more detail, we used one of the best-studied kinesins, KIF1A, as our representative motor protein and tested whether KBP binds directly to the motor domain of KIF1A (KIF1A-MD). His-KIF1A-MD co-eluted in the presence of an excess of untagged KBP ( Figure 1J , lane 2), thus demonstrating a direct interaction between KBP and the motor domain of KIF1A. In contrast, His-KIF21B-MD did not co-elute with KBP, indicating that the interaction is specific for KIF1A-MD ( Figure 1J, lane 3) . To assess the stoichiometry of the KBP/His-KIF1A-MD complex, we performed MALS experiments with the co-purified complex and obtained a molecular weight of 112.9 kDa ( Figure 1K ), which is consistent with the molecular weight for a 1:1 complex between KBP (71.9 kDa) and His-KIF1A-MD (41 kDa).
Next, we aimed to identify a mechanism that could regulate the KBP-kinesin interaction. Because phosphorylation is an important mechanism to regulate motor function [19] , we tested whether binding between kinesin and KBP is regulated by phosphorylation. HEK293 cells expressing a panel of KBP-associated KIFs were treated with the phosphatase inhibitor okadaic acid to induce hyperphosphorylation or with the protein kinases inhibitor staurosporine to induce protein dephosporylation ( Figure 1H ). In addition, recombinant lambda protein phosphatase was added to staurosporin samples to remove additional phosphate groups ( Figure 1I ). Whereas the treatments did not change the expression of KBP, they reduced the binding of KBP to some kinesins, particularly KIF1A ( Figures 1H and 1I ). Together, these data demonstrate that KBP binds specifically to the motor domain of a defined subset of kinesin motor proteins and that phosphorylation increases the binding between KBP and some kinesins.
KBP Inhibits KIF1A Motility by Preventing the Association with Microtubules
Because KBP binds specifically to the motor domain of KIF1A, we reasoned that KBP might interfere with the ability of the kinesin to bind to MTs. To test this, we imaged the localization of dimeric GFP-tagged KIF1A (dKIF1A-MDC), generated by fusing the kinesin-1 coiled-coil stalk to the monomeric KIF1A motor domain [20] , on mCherry-a-tubulin-labeled MTs in COS-7 cells by total internal reflection fluorescence (TIRF) microscopy. Coexpression of HA-KBP decreased the KIF1A intensity along MTs by $80% (Figures 2A and 2B ). In line with these findings, we observed a strong effect of KBP on the association of dKIF1A-MDC with MTs using MT pelleting assays. dKIF1A-MDC-GFP expressed in HEK293 cells robustly bound to Taxolstabilized MTs in the absence of KBP, whereas addition of purified KBP strongly decreased MT-KIF association as evidenced by an increased dKIF1A-MDC-GFP fraction observed in the supernatant after centrifugation ( Figure 2C ). These results were confirmed using recombinant purified proteins: increasing the concentration of KBP reduced the amounts of KIF1A-cMD recovered in the pellet fraction ( Figure 2D ). In contrast, addition of purified KBP did not affect the MT association of KIF21B-MD ( Figure 2E ), a kinesin that was not found to interact with KBP ( Figure 1D ). Micrographs of these pellet fractions verify that MTs are decorated with KIF1A-cMD, as can be observed as small white puncta along the MT, whereas in presence of KBP, they are not ( Figure 2F ). This observation can be visualized by calculating the fast Fourier transforms (FFTs) of MT segments, which amplifies repetitive patterns. Consistently, MTs alone show a 4 nm periodicity [21] and MTs mixed with KIF1A-cMD a 4 nm and 8 nm periodicity, and, as expected, addition of KBP resulted in loss of the 8 nm periodicity ( Figure 2G ). These findings suggest that KBP reduces binding of KIF1A-cMD to MTs. Although KBP was previously suggested to associate with the MT cytoskeleton [16, 17] , we did not observe a direct interact of KBP with MTs in pelleting assays ( Figure S1E ). Together, these data demonstrate that KBP prevents binding of KIF1A to MTs. Because the biochemical experiments showed that KBP inhibits the association of KIF1A with MTs, we next examine the effect of KBP on KIF1A movement along MTs using an in vitro single-molecule motility assay [22] . To visualize the motility of individual KIF1A motors, we added extracts of HEK293 cells expressing GFP-tagged, dimeric KIF1A (dKIF1A-MDC) to surfaceimmobilized MTs ( Figure 2H ). Single-KIF1A motors could be observed as distinct fluorescent spots moving unidirectionally along MTs ( Figure 2I ; Movie S1), and their binding and motility were analyzed using kymographs. Consistent with our MT binding and electron microscopy data (Figures 2A-2G ), we observed a strong reduction in the amount of KIF1A motors associating with MTs after addition of purified KBP ( Figure 2J ). In the presence of KBP, the number of single KIF1A motors that associated with surface-immobilized MTs was reduced by $75% compared to control ( Figure 2K ). An even greater reduction of $85% was observed for the amount of KIF1A motors that were able to move along MTs after addition of KBP ( Figure 2L ). The few remaining motile particles showed a considerably shorter run length compared to control ( Figure 2M ) and showed only modest increase in the velocity ( Figure 2N ). Together, these findings show that KBP inhibits kinesin activity by preventing the association of the kinesin with MTs.
KBP Inhibits Kinesin-Based Cargo Motility in Living Cells
As KBP affects the motility of kinesin along MTs, we hypothesized that KBP might control kinesin-mediated cargo transport. To test this idea, we made use of our previously developed cargo-trafficking assay where FRB-FKBP heterodimerization triggers the coupling of a motor protein of interest to an artificial cargo (in this case, peroxisomes) after addition of the rapamycin analog AP21967 (rapalog; Figure 3A ) [23, 24] . In COS-7 cells cotransfected with PEX-RFP-FKBP and KIF-MDC-FRB constructs, most peroxisomes displayed a perinuclear localization before rapalog addition (0 min; Figure 3B ). Treating these cells with rapalog revealed a robust accumulation over time of peroxisomes at the cell periphery, near MT plus ends (Figures 3B and 3E) . Co-expressing peroxisome targeting and kinesin motor constructs together with full-length HA-KBP prevents the directional translocation of peroxisomes to the cell periphery by all KBP-interacting kinesins, but, as expected, not by KIF5B or KIF21B ( Figures  3C-3G , S2A, and S2B; Movies S2 and S3). These findings suggest that KBP inhibits cargo transport driven by a specific subset of kinesin motors. Importantly, expression of HA-KBP in COS-7 cells does not interfere with the heterodimerization system itself ( Figures 3C, 3D, and S2E) . Consistent with the pull-down experiments ( Figures 1B and S1C) , the co-expression of truncated fragments of KBP was not able to inhibit the translocation of KIF1A ( Figures S2C and S2D ). All these findings were further confirmed using fixed HeLa cells treated with rapalog for different time intervals (Figures S2F-S2H ). Collectively, these findings indicate that KBP inhibits kinesin activity by preventing the association of the kinesin with MTs.
KBP Controls Microtubule Dynamics in Neurons
KBP has previously been reported to be required for axonal development in zebrafish [18] . Therefore, we investigated the role of KBP in axonal outgrowth using primary cultured hippocampal neurons. We transfected neurons at DIV0 with HA-KBP for 4 days and found that overexpression of KBP resulted in reduced axon length ( Figures S3A and S3B) . In contrast, depletion of KIF1A using small hairpin RNA (shRNA) did not result in a similar decrease in axon outgrowth, consistent with the absence of clear morphological phenotypes in KIF1A-deficient neurons [25] . Either increasing or decreasing KBP levels results in a high number of neurons with Golgi fragmentation, similar to the KIF1C knockdown phenotype (Figures S3C and S3D) . Interestingly, electron microscopy analysis of KBP zebrafish mutants revealed MT defects [18] , although the exact mechanism has remained unresolved. Therefore, we tested the effect of KBP on MT dynamics in neurons by expressing GFP-MACF43 (GFP-MT+TIP) to specifically label growing MT plus ends using livecell imaging [26] (Figure 4A ). Expression of HA-KBP greatly affects several parameters of MT dynamics, such as the MT growth length, growth rate, and catastrophe frequency compared to control cells (Figures 4B-4D ). As KBP functions as a kinesin inhibitor, we reasoned that reduced levels of a MT-dynamics-regulating kinesin should display similar effects on MT dynamics as KBP overexpression. From the KBP-interacting kinesins, only KIF18A, a member of the kinesin-8 family, is known to function as a MT-depolymerizing kinesin during mitotic chromosome positioning [27, 28] . Depletion of KIF18A affects MT dynamics in post-mitotic neurons, similar to KBP overexpression ( Figures 4A-4D ) which could be rescued by co-expression of full-length KIF18A (Figures 4A-4D) . We observed an increase in catastrophe frequency in KIF18A knockdown neurons, which is unexpected for a MT-depolymerizing kinesin, but this effect has been reported before for kinesin-8 family members [29] . The MT growth rate was increased in KIF18A depleted ( Figure 4C ), which is in line with a role of KIF18A in promoting MT pausing [27, 28] . As expected, KIF1A depletion had no effect on catastrophe frequency or growth length ( Figures 4A-4D ). Because various depolymerizing kinesins have been implicated in axon outgrowth [30] , we tested the effect of KIF18A depletion and observed a decrease in axon length, comparable to KBP overexpression ( Figures S3A  and S3B ). Together, these data suggest that KBP controls MT dynamics by controlling the activity of MT-regulating kinesins.
KBP Controls KIF1A-Mediated Synaptic Vesicle Distributions As we found that KBP controls kinesin-mediated cargo trafficking in cells, and as KBP mutant zebrafish show aberrant organelle accumulations in the axon [18] , we next determined the role of KBP in axonal cargo transport. HA-KBP localizes to the cytoplasm with a variety of distinct puncta scattered throughout the cell body, axon, and dendrites, which do not specifically coincide with neuronal cargoes, such as Rab3-positive synaptic vesicle precursors, autophagosome adaptor LC3, or mitochondria ( Figure 4E ). Because KBP interacts with KIF1A ( Figures 1A and 1D) , which mediates axonal transport of Rab3-positive synaptic vesicle precursors [25, 31, 32] , we studied the effect of KBP on KIF1A localization. We transfected DIV4-cultured hippocampal neurons with myc-KIF1A together with KBP overexpression or knockdown constructs for 4 days. Changing the level of KBP resulted in a marked change in KIF1A localization: knockdown of KBP resulted in an increase of KIF1A in the distal tips of neurites, whereas HA-KBP expression leads to a KIF1A accumulation in the proximal axon ( Figures  4F and 4G ). As expected, the KIF1A-mediated cargo Rab3 followed a comparable distribution upon KBP depletion and overexpression ( Figures 4H-4J ). Control hippocampal neurons showed GFP-Rab3-labeled synaptic vesicles in the cell body and in proximal and distal axons, whereas KBP-depleted cells showed a strong increase in Rab3 intensity in the distal axon ( Figures 4H-4J) , similar to the overexpression of HA-KIF1A and HA-KIF1Bb ( Figures 4H-4J ), another KBP-associated kinesin implicated in Rab3 transport. In contrast, overexpression of KBP resulted in a marked decrease in Rab3 intensity in the distal axons ( Figures 4H-4J ) and increased Rab3 intensity in the cell body ( Figure 4K ), similar to KIF1A depletion ( Figures 4F and  4G) , which is in line with previous findings on synaptic vesicle distributions in KIF1A-deficient mice [25] . Consistently, increased or decreased levels of KBP leads to an increase or decrease in the number of neurons displaying Rab3 accumulations in the cell body, respectively ( Figure 4L ). Simultaneous depletion of KIF1A or KIF1B was able to rescue the effect of HA-KBP on Rab3 accumulation in the cell body ( Figure 4L ). These findings show that KBP is required for the normal distribution of synaptic vesicle precursors in hippocampal neurons and indicate that KBP prevents the transport of Rab3 vesicles by inhibiting kinesin motor activity.
Next, we studied the role of KBP in controlling Rab3 distributions in C. elegans, as an in vivo model system. In contrast to mammals, C. elegans does not have a gene encoding for KBP. We therefore generated transgenic worms expressing GFPtagged human KBP in PVD sensory neurons ( Figure 4M ) and examined the axonal targeting of the presynaptic marker RAB-3, which depends on UNC-104/KIF1A [33] . To verify that KBP is able to bind UNC-104, we performed immunoprecipitation experiments in HEK293 cells using a construct containing (legend continued on next page) the motor domain and the first coiled coil (MDC) of UNC-104 ( Figure S1F ). In wild-type animals, presynaptic specializations are largely restricted to the axon in the ventral nerve cord of the PVD [33] . Expression of GFP-KBP alters the distributions of RAB-3-mCherry, resulting in mislocalization of the synaptic vesicles from the axon to the cell body and in the anterior dendrite ( Figures 4N and 4O ). These observations suggest that KBP alters the UNC-104/KIF1A-mediated distribution of synaptic vesicles.
Collectively, these results demonstrate that KBP inhibits KIF1A-dependent synaptic vesicle distribution.
KBP Regulates Transport of Axonal Cargoes
Because KBP regulates the distribution of Rab3 vesicles in neurons, we next determined the effect of KBP on the motility of synaptic vesicles. First, we transfected DIV4-cultured hippocampal neurons with GFP-Rab3 for 4 days and followed their movements in axons using live-cell microscopy ( Figure 5A ; Movie S4). Co-expression of HA-KBP resulted in a strong decrease of motile Rab3 vesicles and in an increase of static vesicles in axons, whereas KBP depletion showed the opposite effect (Figures 5B and 5C ). Using kymographs, we analyzed the velocities of moving Rab3 vesicles and observed an average velocity of 1.21 ± 0.05 mm/s for anterograde moving vesicles in control neurons ( Figures 5D and S4A) , which is consistent with reported velocities [34] [35] [36] . Compared to control, we observed a significant decrease in anterograde Rab3 vesicle speed after co-expression of HA-KBP to 0.81 ± 0.05 mm/s (Figures 5D and S4A ). As expected, depletion of KIF1A showed the same effect on Rab3 vesicle motility as KBP overexpression ( Figures 5D and S4A ). In contrast, Rab3 vesicles moved faster toward the distal axon upon depletion of KBP with an average velocity of 1.76 ± 0.11 mm/s ( Figures 5D and S4A) , which is comparable with the velocity of KIF1A in the in vitro motility assay ( Figure 2N ). Although less pronounced, a similar effect of KBP overexpression and knockdown was observed for Rab3 vesicles moving in a retrograde direction ( Figures 5C and S4B ). The observed Rab3-trafficking defects in KBP overexpression and knockdown neurons was not due to altered MT dynamics because we found no alterations in the axonal MT polarity ( Figures S4C and S4D ) or defects in Rab3 motility upon changes in KIF18 activity levels ( Figures S4E and S4F ). KIF5 and dynein, motors that do not bind KBP ( Figures 1B-1D ), are the main motors that drive both axonal mitochondrial and autophagosome transport [37] [38] [39] . In contrast, overexpression of KBP does not modulate the velocity and number of anterograde moving mitochondria (Figures 5F, 5G, and 5I) or the velocity of anterograde autophagosome transport ( Figures 5J and 5K) , which is consistent with their KIF5-mediated transport. However, KBP depletion affects the velocity and number of retrograde moving mitochondria ( Figure 5I ) and the number of retrograde moving autophagosomes ( Figure 5M ), suggesting that some KBP-associated kinesin motors play an additional role in coordinate bidirectional axonal transport. These findings support the idea that motor teams of opposite polarity are required for driving efficient cargo transport [40] . Collectively, our findings indicate that KBP regulates the trafficking of axonal cargoes by controlling kinesin activity.
DISCUSSION KBP Controls Microtubule Dynamics and Cargo Transport
It has been shown that KBP is required for axonal outgrowth and maintenance in zebrafish kbp-null mutants [18] ; axons show reduced growth during development and undergo degeneration at later stages. Moreover, electron microscopy analysis revealed aberrant cargo accumulations in the axon and an abnormal distribution of synaptic vesicles [18] . Our findings in KBP-depleted hippocampal neurons are consistent with the reported observations in zebrafish kbp mutants, as we observed impaired neuronal development and abnormal localization of synaptic vesicle precursors. It has previously been suggested that KBP is a MT-associated protein whose main role is to regulate MT organization in neurons [16, 17] . It has also been proposed that the abnormal cargo localization observed in zebrafish mutants might occur as a secondary effect of the altered MT cytoskeleton [18] . In contrast to these conclusions, we found that KBP does not directly bind to MTs but can alter MT dynamics by inhibiting the activity of MT-depolymerizing kinesins, such as KIF18A. Our results suggest that KBP influences kinesins that are required for both MT cytoskeleton organization and neuronal cargo transport mechanisms. Therefore, we propose that the primary function of KBP is to regulate a subset of kinesins required for distinct neuronal kinesin-dependent processes.
KBP-Controlled Kinesin Motor Activity Is Required for Distinct Neuron Developmental Processes
In this study, we have mainly used KIF1A as a representative motor protein to investigate the KBP-kinesin interaction in biochemical, biophysical, and cellular experiments. Our data suggest that KBP functions as a regulator of KIF1A motor activity and controls KIF1A-mediated synaptic vesicle precursor (Rab3) transport in hippocampal neurons. We found that KBP not only interacts with KIF1A but also with several other kinesin family members. Defects in multiple KBP-controlled kinesin pathways could together account for the axonal outgrowth and synaptic vesicle phenotypes observed in KBP-deficient neurons and in KBP mutant zebrafish [18] . Because KIF1A-deficient neurons do not show clear morphological alterations during development [25] , our observed axonal defects could be attributed to the impairment processes mediated by other KBP-controlled kinesins. For example, KIF13B is known to be involved in neurite extension via the transport of PIP3-containing lipid vesicles to the axon tips [41] [42] [43] [44] . In addition, we demonstrated that alterations in MT dynamics and mediated by KIF18A [27, 28] may, at least partly, account for the developmental defects. Interestingly, in this respect are the findings that homozygous nonsense mutations in the gene encoding KBP were linked to GOSHS [10] [11] [12] . Future studies should address whether misregulation of a specific set of KBP-controlled kinesins contribute to the neuropathological defects observed in GOSHS patients.
KBP Provides a Novel Mechanism for Controlling Kinesin Activity
Using single-molecule in vitro assays, we found that KBP inhibits kinesin motility by blocking the association of KIF1A with MTs. However, unlike autoinhibition, the inhibitory function of KBP is not restricted to cytoplasmic motors but can also block cargoattached kinesin movement. These observations imply that KBP binding to kinesins may be able to directly control the bidirectional movement of axonal cargos that are transported by opposing motors. Moreover, as seen for mitochondria and autophagosome trafficking, the repertoire of KBP-controlled kinesins and other motors bound to transport vesicles will dictate the exact transport parameters and allow precise spatial and temporal regulation to ensure proper motility and delivery of specific cargoes. The simplest model for how KBP controls kinesin function is the one in which KBP binding to the motor domain inhibits kinesin activity and where release of KBP activates kinesin motors to allow kinesin function. We found that phosphorylation enhances the binding between KBP and KIF1A. Investigating whether local kinase signaling affects the activity of KBP and whether other post-translational modifications influence kinesin-KBP complex formation will be important topics for future studies. Because we found that KBP interacts with a subset of partially unrelated motor proteins, it remains an intriguing question why KBP preferentially binds and inhibits the motility of this specific set because we could not identify an obvious consensus sequence in their motor domains. Solving the high-resolution structure of the KBP-kinesin complex will be necessary to resolve this issue.
EXPERIMENTAL PROCEDURES Animals and Ethics Statement
All animal experiments were performed in compliance with the guidelines for the welfare of experimental animals issued by the federal government of the Netherlands. All animal experiments were approved by the Animal Ethical Review Committee (DEC) of the Erasmus Medical Center and Utrecht University.
Antibodies and Reagents
Two independent anti-KBP antibodies were generated by immunizing rabbits with a short peptide encompassing aa 24-38 of mouse KBP (Eurogentec) and glutathione S-transferase (GST)-KBP (aa 1-292) fusion proteins. Details of KBP antisera and other antibodies and reagents are in the Supplemental Experimental Procedures.
DNA and shRNA Constructs
The KBP expression constructs were generated by a PCR-based strategy using the human KBP cDNA (KIAA1279; IMAGE clone 4550085). The KBPshRNA sequence (5 0 -TATCATAGTAAGCATGTGCTT) targeting rat KBP mRNA (NP_001026797) was based on the effective human KBP no. 1 siRNA sequence and inserted into a pSuper vector. See the Supplemental Experimental Procedures.
Protein Purification and Biophysical Characterization KBP was expressed in Rosetta2 cells, lysed, and purified by immobilized metal-affinity chromatography (IMAC) followed by size-exclusion chromatography. MALS was performed using an S-200 analytical size-exclusion chromatography column connected in line to a mini-DAWN TREOS light-scattering and Optilab T-rEX refractive index detectors. For details, see the Supplemental Experimental Procedures.
In Vitro Kinesin Motility Assay
MTs labeled with rhodamine-conjugated tubulin were stabilized and attached to a glass coverslip. Dimeric GFP-tagged KIF1A was expressed in HEK293 cells, and cell lysates were added, in the presence of ATP, to the stabilized MTs and incubated with or without purified KBP. For details, see the Supplemental Experimental Procedures.
Data Representation and Statistics
In all bar graphs, data are presented as mean values ± SEM. Data samples were tested for normal distribution. The independent t test or the nonparametric Mann-Whitney U was used for pairwise comparisons. For multiple comparisons, the Kruskal-Wallis test with pairwise comparisons was used. n indicates the number of independent experiments. 
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